Wells Fargo Starts Gilead Sciences (GILD) at Outperform, Valuation Range $48-$52

December 10, 2010 8:29 AM EST Send to a Friend
Wells Fargo resumes coverage on Gilead Sciences (NASDAQ: GILD) with an Outperform rating and a valuation range of .$48-$52.

This article: 99 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login